Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1995 3
1996 1
1997 1
2000 1
2001 1
2003 2
2004 2
2008 1
2009 2
2010 3
2011 2
2014 2
2015 6
2016 11
2017 5
2018 2
2019 3
2020 6
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE Therapy.
O'Neill E, Kersemans V, Allen PD, Terry SYA, Torres JB, Mosley M, Smart S, Lee BQ, Falzone N, Vallis KA, Konijnenberg MW, de Jong M, Nonnekens J, Cornelissen B. O'Neill E, et al. Among authors: konijnenberg mw. J Nucl Med. 2020 May;61(5):743-750. doi: 10.2967/jnumed.119.232934. Epub 2019 Nov 22. J Nucl Med. 2020. PMID: 31757844 Free PMC article.
MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy.
Ljungberg M, Celler A, Konijnenberg MW, Eckerman KF, Dewaraja YK, Sjögreen-Gleisner K; SNMMI MIRD Committee, Bolch WE, Brill AB, Fahey F, Fisher DR, Hobbs R, Howell RW, Meredith RF, Sgouros G, Zanzonico P; EANM Dosimetry Committee, Bacher K, Chiesa C, Flux G, Lassmann M, Strigari L, Walrand S. Ljungberg M, et al. Among authors: konijnenberg mw. J Nucl Med. 2016 Jan;57(1):151-62. doi: 10.2967/jnumed.115.159012. Epub 2015 Oct 15. J Nucl Med. 2016. PMID: 26471692 Free article.
Errare humanum est, sed in errare perseverare diabolicum: methodological errors in the assessment of the relationship between I-131 therapy and possible increases in the incidence of malignancies.
Verburg FA, Hoffmann M, Iakovou I, Konijnenberg MW, Mihailovic J, Gabina PM, Ovčariček PP, Reiners C, Vrachimis A, Zerdoud S, Giovanella L, Luster M. Verburg FA, et al. Among authors: konijnenberg mw. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):519-522. doi: 10.1007/s00259-019-04580-5. Eur J Nucl Med Mol Imaging. 2020. PMID: 31807882 No abstract available.
Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle.
Garousi J, von Witting E, Borin J, Vorobyeva A, Altai M, Vorontsova O, Konijnenberg MW, Oroujeni M, Orlova A, Tolmachev V, Hober S. Garousi J, et al. Among authors: konijnenberg mw. Biomaterials. 2021 Jan;266:120381. doi: 10.1016/j.biomaterials.2020.120381. Epub 2020 Oct 17. Biomaterials. 2021. PMID: 33120197 Free article.
Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy.
Ruigrok EAM, van Vliet N, Dalm SU, de Blois E, van Gent DC, Haeck J, de Ridder C, Stuurman D, Konijnenberg MW, van Weerden WM, de Jong M, Nonnekens J. Ruigrok EAM, et al. Among authors: konijnenberg mw. Eur J Nucl Med Mol Imaging. 2020 Oct 23. doi: 10.1007/s00259-020-05057-6. Online ahead of print. Eur J Nucl Med Mol Imaging. 2020. PMID: 33094433
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate.
Bergsma H, Konijnenberg MW, van der Zwan WA, Kam BL, Teunissen JJ, Kooij PP, Mauff KA, Krenning EP, Kwekkeboom DJ. Bergsma H, et al. Among authors: konijnenberg mw. Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1802-11. doi: 10.1007/s00259-016-3382-9. Epub 2016 May 10. Eur J Nucl Med Mol Imaging. 2016. PMID: 27160225 Free PMC article.
Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177 Lu-DOTAGA-PEG2 -RM26.
Mitran B, Rinne SS, Konijnenberg MW, Maina T, Nock BA, Altai M, Vorobyeva A, Larhed M, Tolmachev V, de Jong M, Rosenström U, Orlova A. Mitran B, et al. Among authors: konijnenberg mw. Int J Cancer. 2019 Dec 15;145(12):3347-3358. doi: 10.1002/ijc.32401. Epub 2019 May 23. Int J Cancer. 2019. PMID: 31077356 Free PMC article.
55 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page